- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Ashfield Engage Partners with ysura to “Transform HCP and Pharma Interactions” in Europe
Ashfield Engage (Ashby-de-la-Zouch, UK), a strategic engagement and commercialization partner for the healthcare industry, has partnered with ysura (Munich, Germany), a SaaS company specializing in healthcare, to enhance its HCP engagement services in Europe through a “seamless omnichannel solution.”
Ashfield Engage helps clients engage with healthcare professionals (HCPs) through a blend of sales, account management and medical science liaison teams across digital, virtual and in-person channels. ysura’s proprietary, cloud-based Customer Interaction Platform helps them more precisely reach audience segments and provide richer and more personalized HCP conversations.
The Ashfield Engage Customer Engagement Platform powered by ysura will be rolled out across Europe in early 2022.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
